Telehealth & Digital Health

A landmark Nature Medicine publication for OrsoBio's TLC-2716 offers new hope for millions suffering from severe lipid and liver disorders.

The global digital immunoassay market is set to triple, promising to find diseases earlier than ever. But can healthcare systems overcome the high cost?

Jennifer Erickson, a mentee of the retiring CEO, returns to lead Arizona's top lab, signaling a new era of innovation amid industry-wide shifts.

A sudden collapse led to a rare cancer diagnosis for a NJ teen. His story of recovery highlights a therapy that targets tumors while sparing young minds.

Reimbursements are falling and costs are rising, but top allergy practices are boosting revenue by 22%. A new report reveals their data-driven secrets.

A new alliance in healthcare marketing merges pharmaceutical expertise with provider-side insights, leveraging AI and big data to fix a fragmented system.

Rapid health checks are transforming cardiovascular care in London, as a new initiative expands to 70 pharmacies, shifting services from hospitals to the high street.

A new partnership embeds at-home diagnostics into Innovaccer's AI platform, aiming to revolutionize how health plans close care gaps and manage risk.

The FDA has expanded clearance for iotaMotion's robotic-assisted system, offering a new level of surgical precision for children with profound hearing loss.

A new partnership reveals how integrating mental health is revolutionizing oncology, improving patient outcomes, and setting a new standard for whole-person care.

One of the nation's largest health systems is expanding its use of advanced AI and analytics to redefine clinical excellence and whole-person care.

As Disc Medicine nears a potential drug launch, its new HR chief hire reveals a critical strategy for navigating biotech's intense talent wars.

With new federal guidelines backing whole foods, programs delivering 'prescription produce' are proving they can cut healthcare costs and fight chronic disease.

New 2025 data reveals an AI platform is slashing costs, improving chronic disease outcomes, and closing health equity gaps for hundreds of clinicians.

Biomea Fusion launches a high-stakes 2026 plan, advancing a novel diabetes drug to restore insulin cells and an oral pill to rival obesity giants.

With its new thalassemia drug AQVESME launching, Agios aims for blockbuster status while navigating a key safety warning and advancing a broad pipeline.

Teladoc Health's enhanced service integrates specialist consults and data analytics, moving beyond urgent care to reshape healthcare costs and patient outcomes.

As its single-dose glaucoma therapy nears trials, Diorasis adds a seasoned dealmaker to its board, signaling a strategic shift toward market entry.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

After resolving manufacturing hurdles, Camurus' self-administered acromegaly treatment Oclaiz is back on track for US approval, promising new hope for patients.